Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01086202 · ClinicalTrials.gov registry record

Clinical Outcome Comparison Between Medial and Lateral Offset Reverse Shoulder Arthroplasty

A clinical trial, sponsored by Loma Linda University.

Completed
Registry status
37
Enrollment target

NCT01086202: Completed study, sponsored by Loma Linda University.

NCT01086202 is a clinical trial that has completed, run by Loma Linda University. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01086202 has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
37 participants
Enrollment target

Study Summary

The purpose of this study is to prospectively evaluate two FDA approved implant designs for the Tornier Reverse Shoulder arthroplasty. The small difference in design is the amount of offset each implant has. This offset may improve clinical outcomes in the patient population. There have been no clinical comparative studies between these two designs in the literature to date. We would like to follow these patients for two years after implantation of the reverse shoulder and evaluate their radiographs, pain scores, and shoulder functional scores. this would be the first randomized prospective single blinded study of its kind.

Primary Outcome

We would like to follow these patients for two years after implantation of the reverse shoulder and evaluate their radiographs, pain scores, and shoulder functional scores. this would be the first randomized prospective single blinded study of its kind.

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2010-05
Est. Completion 2014-10
Loma Linda University

237 total trials

What the finished NCT01086202 record still lists

NCT01086202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01086202 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01086202 about?

NCT01086202 is a clinical study titled "Clinical Outcome Comparison Between Medial and Lateral Offset Reverse Shoulder Arthroplasty". The purpose of this study is to prospectively evaluate two FDA approved implant designs for the Tornier Reverse Shoulder arthroplasty. The small difference in design is the amount of offset each implant has. This offset may improve clinical outcomes in the patient population. There have been no clin...

What is the current status of trial NCT01086202?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2010-05. Estimated completion is 2014-10.

Who is sponsoring clinical trial NCT01086202?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01086202, the US trial registry maintained by the National Library of Medicine. NCT01086202 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.